Peter Keov
Parkville, VIC 3052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
De novo design of miniprotein agonists and antagonists targeting G protein-coupled receptors.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors.
Journal: Nature communications
Published: June 28, 2024
Discovery and development of macrocyclic peptide modulators of the cannabinoid 2 receptor.
Journal: The Journal of biological chemistry
Published: February 21, 2024
Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide Agonists.
Journal: Molecular pharmacology
Published: December 20, 2023
Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists.
Journal: British journal of pharmacology
Published: October 03, 2023
Role of G protein-coupled receptor kinases (GRKs) in β2 -adrenoceptor-mediated glucose uptake.
Journal: Pharmacology research & perspectives
Published: September 12, 2023
AM833 Is a Novel Agonist of Calcitonin Family G Protein-Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists.
Journal: The Journal of pharmacology and experimental therapeutics
Published: February 12, 2021
Orphan receptor GPR37L1 remains unliganded.
Journal: Nature chemical biology
Published: August 19, 2020
I8-arachnotocin-an arthropod-derived G protein-biased ligand of the human vasopressin V2 receptor.
Journal: Scientific reports
Published: September 05, 2019
Last Updated: 09/26/2026